WHO ICTRP trial
A Multicenter, Randomized Controlled, Open-label Clinical Trial Comparing…
ChiCTR2400092383 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400092383 |
|---|---|
| Public title | A Multicenter, Randomized Controlled, Open-label Clinical Trial Comparing Upfront Transplantation and Pretransplant Cytoreductive Therapy in Intermediate High-risk/High-risk/Very High-risk Myelodysplastic Syndromes (MDS) Patients Based on the IPSS-M Scoring System |
| Scientific title | A Multicenter, Randomized Controlled, Open-label Clinical Trial Comparing Upfront Transplantation and Pretransplant Cytoreductive Therapy in Intermediate High-risk/High-risk/Very High-risk Myelodysplastic Syndromes (MDS) Patients Based on the IPSS-M Scoring System |
| Primary sponsor | Shanghai Zhaxin integrated traditional Chinese and Western Medicine Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Myelodysplastic Syndrome (MDS) Patients with Intermediate High, High, and Very High Risk According to the IPSS-M Scoring System |
| Interventions | Pretransplant cytoreductive therapy:Pretransplant cytoreductive therapy;Upfront transplantation:Upfront transplantation |
| Registration date | Nov 14, 2024 |
| Target size | Pretransplant cytoreductive therapy:63;Upfront transplantation:63 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: